<DOC>
	<DOCNO>NCT02045121</DOCNO>
	<brief_summary>Malignant pleural effusion ( MPE ) account 50 % pleural effusion affect 300,000 patient annually ( UK USA ) . Lung breast cancer account majority malignant pleural effusion ; 1 3 breast cancer , 1 4 lung cancer well &gt; 90 % patient mesothelioma develop pleural effusion . Breathlessness MPE disable impairs quality life . Median survival range 4-6 month . Although thoracentesis provide effective symptom relief , effusion recur pleurodesis standard care . Pleurodesis perform via chest tube apply pleuroscopy , talc effective agent . For successful pleurodesis occur underlie lung must expand fluid drainage trap lung due metastatic disease occur 30 % . Symptomatic patient require hospitalization procedure likely fail trap lung encounter , pose significant burden health service . Tunneled indwell pleural catheter ( IPC ) emerge viable alternative provide access pleural space fluid drainage breathlessness arise . IPC perform ambulatory setting without hospital admission . Case series demonstrate long-term safety IPC even patient undergo chemotherapy acceptable complication rate . By keep pleural cavity free fluid , IPC lead spontaneous pleurodesis 50 % patient , allow removal . Presently IPC indicate trap lung talc pleurodesis fail . A randomised comparative trial talc pleurodesis necessary determine role IPC first-line therapy MPE , IPC lead reduction hospitalization , adverse event healthcare cost , improve quality life . The multicenter trial randomize symptomatic patient 1:1 IPC talc pleurodesis , endpoint include hospitalization day till death end study , adverse event , quality life , healthcare cost .</brief_summary>
	<brief_title>Multicentre Study Comparing Indwelling Pleural Catheter With Talc Pleurodesis Malignant Pleural Effusion Management</brief_title>
	<detailed_description />
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<criteria>Symptomatic malignant pleural effusion require intervention &lt; 18 year age pregnant lactating patient expect survival &lt; 3 month chylothorax previous attempted pleurodesis pleural infection leukocytopaenia ( &lt; 1.0 x 10^9/L ) uncorrectable bleed diathesis inability give inform consent comply protocol</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>